Research Comparison

BPC-157 vs TB-500

Side-by-side research comparison of BPC-157 and TB-500 across our PubMed, ClinicalTrials.gov, and EuropePMC corpus. 4 head-to-head studies plus 115 on BPC-157 and 17 on TB-500.

4 head-to-head · 115 on BPC-157 · 17 on TB-500

At a glance

  BPC-157 TB-500
Drug class healing peptide, gastric pentadecapeptide healing peptide, thymosin
Studies in corpus 115 17
Highest evidence tier meta analysis review
Evidence tier mix review · 20 other · 10 in vitro · 5 preclinical animal · 67 rct · 3 meta analysis · 1 review · 6 in vitro · 3 other · 6 preclinical animal · 2
Studies with explicit sample size 1 0
Head-to-head studies in corpus 4

Lab evidence, head to head

Beyond the literature: here's what third-party Certificate-of-Analysis records (Janoshik, BCC, Auxlabs) say about real BPC-157 and TB-500 batches we've tested. Aggregate, public data — cross-reference against the studies below.

BPC-157

We tested 4108 BPC-157 batches across 1149 manufacturers, 99.14% avg purity.

4108
Batches tested
1149
Manufacturers
99.14%
Avg purity
19
Failed <90%
237
Underdosed >10%
All BPC-157 COA records →

TB-500

We tested 2228 TB-500 batches across 786 manufacturers, 99.0% avg purity.

2228
Batches tested
786
Manufacturers
99.0%
Avg purity
16
Failed <90%
72
Underdosed >10%
All TB-500 COA records →

We hold deeper lab coverage on BPC-157 (4108 batches tested). BPC-157 edges ahead on average measured purity (99.14% vs 99.0%) — a narrow gap; weigh it against failed-batch and underdose counts above.

Head-to-head studies

Studies in our corpus that mention both BPC-157 and TB-500 — the gold-standard direct comparison evidence.

Top studies per peptide

Vendor data

Looking for vendor-level purity, endotoxin, and HPLC data on BPC-157 or TB-500? TitrateLab tracks Certificate-of-Analysis records from the major peptide labs (Janoshik, BCC, Auxlabs) alongside the research above. Cross-reference vendor batches against the studies on this page.

Explore each peptide